CP17640152376551914 — Tysabri(natalizumab) 300mg/15ml [Chas]
$10,402
All-payer median here
$13,870
Cash / self-pay here
4
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.